Future Science Group
Browse
FON-2021-1250 - IFG.pdf (1.41 MB)

Infographic – Encorafenib plus binimetinib in patients with BRAFV600-mutant non-small cell lung cancer: Phase II PHAROS study design

Download (1.41 MB)
figure
posted on 2022-01-31, 09:00 authored by Taylor & FrancisTaylor & Francis, Gregory J Riely, Myung-Ju Ahn, Enriqueta Felip, Suresh S Ramalingam, Egbert F Smit, Anne S Tsao, Ann Alcasid, Tiziana Usari, Paul S Wissel, Keith D Wilner, Bruce E Johnson

Encorafenib plus binimetinib in patients with BRAFV600-mutant non-small cell lung cancer: Phase II PHAROS study design

Infographic – Summary of the article 

History